CONMED Corp. (NASDAQ:CNMD) had its price objective hosited by Piper Jaffray Cos. from $34.00 to $36.00 in a report released on Thursday, AnalystRatings.Net reports. Piper Jaffray Cos. currently has a neutral rating on the stock.
Several other analysts have also recently commented on the stock. Analysts at Ladenburg Thalmann raised their price target on shares of CONMED Corp. from $36.25 to $42.00 in a research note to investors on Thursday. They now have a buy rating on the stock. They noted that the move was a valuation call. Analysts at Zacks reiterated a neutral rating on shares of CONMED Corp. in a research note to investors on Thursday, July 4th. They now have a $33.00 price target on the stock.
CONMED Corp. (NASDAQ: CNMD) traded down 0.24% on Thursday, hitting $33.35. CONMED Corp. has a 52-week low of $25.07 and a 52-week high of $34.86. The stock’s 50-day moving average is currently $32.14. The company has a market cap of $920.1 million and a price-to-earnings ratio of 23.71.
CONMED Corporation (NASDAQ: CNMD) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring.